Dr. Sarantopoulos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
40 Duke Medicine Cir
Durham, NC 27710Phone+1 919-684-8111Fax+1 919-620-4921
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2002 - 2005
- Boston University Medical CenterResidency, Internal Medicine, 1998 - 2002
- Boston University School of MedicineClass of 1998
- Boston University School of MedicinePh.D., 1998
- Mount Holyoke CollegeB.A., Biochemistry, 1988
Certifications & Licensure
- NC State Medical License 2009 - 2025
- MA State Medical License 2001 - 2009
- ABIMHematology
Awards, Honors, & Recognition
- American Society for Clinical Investigation ASCI, 2017
- UNC Excellence Award 2010
- Amy Strelzer Manasevit Scholar 2009
- Join now to see all
Clinical Trials
- Evaluation of Fostamatinib in Patients With cGVHD After Allogeneic Stem Cell Transplant Start of enrollment: 2016 Jan 01
Publications & Presentations
PubMed
- Exploring facilitators and barriers to daily chlorhexidine gluconate bathing in adult patients undergoing hematopoietic stem cell transplantation.Ashley L Artese, Michele Sainvil, Laura J Fish, Lauren Hill, Tamara Somers
Supportive Care in Cancer. 2024-11-28 - Inspiration From Leaders Who Dare To Care.Stefanie Sarantopoulos
Transplantation and Cellular Therapy. 2024-08-01 - 2 citationsType II innate lymphoid cell plasticity contributes to impaired reconstitution after allogeneic hematopoietic stem cell transplantation.Sonia J Laurie, Joseph P Foster 2nd, Danny W Bruce, Hemamalini Bommiasamy, Oleg V Kolupaev
Nature Communications. 2024-07-17
Journal Articles
- Notch Signaling Mediated by Delta-like1/4 Ligands Controls the Pathogenesis of Chronic Graft-Versus-Host Disease in MiceIvan Maillard, Eric T Perkey, Maria A Pletneva, Stefanie Sarantopoulos, Bruce R Blazar, Vedran Radojcic, Blood
- Review: Hematopoietic Stem Cell Transplantation for Scleroderma: Effective Immunomodulatory Therapy for Patients with Pulmonary InvolvementKeith M Sullivan, Ankoor Shah, Daniel E Furst, Stefanie Sarantopoulos, Arthritis & Rheumatology
- A randomized phase II crossover study of imatinib or rituximab for cutaneous sclerosis after hematopoietic cell transplantationAria S, Pidala J, Pusic I, Chai X, Jaglowski S, Khera N, Plamer J, Chen GL, Jagasia M, Mayer SA, Wood WA, Green M, Hyun TS, Inamoto Y, Storer BE, Miklos DB, Shulman HM..., Clin Cancer Res, 1/1/2015
- Join now to see all
Abstracts/Posters
- Evaluation of the Oral SYK Inhibitor Fostamatinib in Patients after Allogeneic Transplantation for Chronic Graft-Versus-Host DiseaseStefanie Sarantopoulos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Decreased Mortality after the First Year of Allogeneic Hematopoietic Stem Cell Transplant in Recipients of Umbilical Cord Blood Vs. Matched Related or Matched Unrelate...Stefanie Sarantopoulos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Geriatric Assessment Identifies Impairments in Younger Candidates for Allogeneic Hematopoietic Stem Cell TransplantationStefanie Sarantopoulos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- B cells in Chronic GVHD1/18/2015
- Burgeoning Roles of B Cells in Transplant1/1/2013
- B Cells and TransplantationTampa, FL - 1/1/2009
Other
- Generation of recombinant polyclonal antibody libraries against tumor cells (thesis)Sarantopoulos S, Boston University School of Medicine
Boston, MA - 1/1/1996 - Separation of monomers and dimmers of glyceraldehydes-3-phosphate dehydrogenase (thesis)Sarantopoulos S, Mt. Holyoke College
South Hadley, MA - 1/1/1988
Press Mentions
- Axatilimab Shows Robust Activity in Chronic Graft-Versus-Host-Disease TrialDecember 20th, 2023
Grant Support
- Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHDNIH (NHLBI)2015–2020
- The Notch2-BCR Axis: Targeting Drivers of B Cell Fate in Chronic GVHDThe Leukemia & Lymphoma Society2015–2018
Committees
- Elected Board Member, Director of Laboratory Sciences for American Society of Bone Marrow Transplantation 2018 - Present
- Invited member, NIH Consensus Criteria on Chronic Graft versus Host Disease, subcommittee on Biology and Biomarkers 2013 - Present
- Invited member, Autoimmune Diseases and Cell Therapy Working for the CENTER FOR INTERNATIONAL BLOOD & MARROW TRANSPLANT RESEARCH (CIBMTR) Committee 2013 - Present
Professional Memberships
- Member
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: